Terms: = Ovarian cancer AND EML4, ENSG00000143924, 27436 AND Clinical Outcome
1 results:
1. Novel targeted therapeutics: inhibitors of MDM2, ALK and PARP.
Yuan Y; Liao YM; Hsueh CT; Mirshahidi HR
J Hematol Oncol; 2011 Apr; 4():16. PubMed ID: 21504625
[TBL] [Abstract] [Full Text] [Related]
